← Pulse/Companies/Compare
Scribe Therapeutics
VS
Shionogi

Biotech comparison — funding, valuation, and investors, sourced from Value Add Pulse coverage.

ST
Scribe Therapeutics

Clinical-stage biotech developing CRISPR-based gene-editing therapeutics using its proprietary CasX enzyme platform.

5 Pulse stories
S
Shionogi

Japanese pharmaceutical company developing prescription drugs, infectious disease therapies, and specialty medicines, including a former sleep apnea drug joint venture with Apnimed.

2 Pulse stories
Total RaisedNot disclosed
Last ValuationNot disclosed
Biotech
Sector
Biotech
2018
Founded
1878
Alameda, California
HQ
Osaka, Japan
Public (SCTX)
Status
Public (4507.T)
Scribe Therapeutics investors
No investors on record.
Shionogi investors
No investors on record.

Data from Value Add Pulse coverage and company research — see the full threads for Scribe Therapeutics and Shionogi.